Your glaucoma patients have seen tremendous things,
and plan to see a whole lot more. That's why the
Hydrus Microstent was purposefully designed for
outcomes that stand the test of time. Choose the MIGS
device built to enable life's biggest experiences.
66% of patients medication-free
1
61% reduction in risk of invasive secondary glaucoma surgeries
1
*
A safety profile similar to cataract surgery alone
1
The only MIGS option proven in a pivotal trial at 5 years to deliver:
©2021 Ivantis, Inc. Ivantis and Hydrus are registered trademarks of Ivantis, Inc. All rights reserved. IM-0098-1 Rev A
Visit Us At ASCRS
Booth #5612
